Literature DB >> 3312938

Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity.

R Firth1, P Bell, R Rizza.   

Abstract

To determine the contribution of obesity to the insulin resistance of non-insulin-dependent diabetes mellitus, insulin dose response curves for suppression of glucose production and stimulation of glucose utilization were generated in lean and obese diabetic patients and compared to those observed in weight-matched nondiabetic subjects. Glucose utilization during 0.4, 1.0, and 10.0 mU/kg x min insulin infusions (producing insulin concentrations ranging from approximately 50 to 2,000 microU/mL) was lower (p less than .02 to .001) in lean and obese diabetic patients compared to weight-matched nondiabetic subjects indicating insulin resistance. Glucose utilization was not correlated with obesity in the diabetic subjects. Suppression of glucose production was impaired (P less than .03 and .001) in both the lean and obese diabetic subjects at physiologic but not supraphysiologic insulin concentrations. We conclude that patients with NIDDM have both hepatic and extrahepatic insulin resistance, the severity of which appears to be independent of the degree of obesity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312938     DOI: 10.1016/0026-0495(87)90031-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

Review 1.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

Review 2.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 3.  Oral antihyperglycemic therapy for type 2 diabetes mellitus.

Authors:  Alice Y Y Cheng; I George Fantus
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

4.  The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

Authors:  D Turk; A Alzaid; S Dinneen; K S Nair; R Rizza
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

5.  Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus.

Authors:  N M O'Meara; J Sturis; E Van Cauter; K S Polonsky
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes.

Authors:  Maziyar Saberi; David Bjelica; Simon Schenk; Takeshi Imamura; Gautam Bandyopadhyay; Pingping Li; Vasant Jadhar; Chandra Vargeese; Weimin Wang; Keith Bowman; Ye Zhang; Barry Polisky; Jerrold M Olefsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

7.  Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D P Rooney; R D Neely; O Beatty; N P Bell; B Sheridan; A B Atkinson; E R Trimble; P M Bell
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

Review 8.  The aetiology and molecular landscape of insulin resistance.

Authors:  David E James; Jacqueline Stöckli; Morris J Birnbaum
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-20       Impact factor: 94.444

9.  Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver.

Authors:  G Bryzgalova; H Gao; B Ahren; J R Zierath; D Galuska; T L Steiler; K Dahlman-Wright; S Nilsson; J-A Gustafsson; S Efendic; A Khan
Journal:  Diabetologia       Date:  2006-02-04       Impact factor: 10.122

10.  Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.

Authors:  T S Berrish; C S Hetherington; K G Alberti; M Walker
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.